A detailed history of Two Sigma Securities, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Two Sigma Securities, LLC holds 15,268 shares of NEO stock, worth $281,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,268
Holding current value
$281,389
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.4 - $17.73 $204,591 - $270,701
15,268 New
15,268 $225,000
Q1 2021

May 17, 2021

SELL
$41.56 - $59.88 $179,414 - $258,501
-4,317 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$36.08 - $56.47 $155,757 - $243,780
4,317 New
4,317 $232,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.32B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.